LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Body Heat Drives New Drug-Delivery Micropump

By LabMedica International staff writers
Posted on 26 Sep 2012
A new study describes a miniature pump powered by fermentation and activated by body heat could be used for the manufacture of drug-delivery patches.

Researchers at Purdue University (Lafayette, IN, USA) have developed a microorganism-powered thermopneumatic pump, which contains Baker's yeast and sugar in a small chamber. When water is added and the patch is placed on the skin, the body heat and the added water causes the yeast and sugar to ferment, generating a small amount of carbon dioxide (CO2) gas, which pushes against a membrane, causing the pump to work continually pump for over two hours. According to the researchers, such miniature pumps could make possible drug-delivery patches that use arrays of microneedles to deliver a wider range of medications than is now possible using conventional patches.

Image: Schematic representation of the Purdue microorganism-powered thermopneumatic pump (Photo courtesy of Purdue University).
Image: Schematic representation of the Purdue microorganism-powered thermopneumatic pump (Photo courtesy of Purdue University).

The pump consists of stacked layers of polydimethylsiloxane (PDMS) and a silicon substrate that form a drug reservoir, and a yeast-solution-filled working chamber. The robustness of yeast allows for long shelf life under extreme environmental conditions. The generation of CO2 is a linear function of time for a given temperature, thus allowing for a controlled volume displacement. The researchers have developed a polymeric prototype with a slow flow rate of less than 0.23 μL per minute and a maximum backpressure of 5.86 kPa. The study describing the new pump was published online on August 24, 2012, in Lab on a Chip.

“Many drugs, including those for treating cancer and autoimmune disorders, cannot be delivered with patches because they are large molecules that won't go through the skin,” said lead author Babak Ziaie, PhD, a professor of electrical and computer engineering and biomedical engineering. “Although transdermal drug delivery via microneedle arrays has long been identified as a viable and promising method for delivering large hydrophilic molecules across the skin, a suitable pump has been hard to develop.”

Related Links:

Purdue University


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Hematology Consumables
Bioblood Devices
New
All-in-One Molecular System
AIO M160

Latest BioResearch News

Innate Immunity Variants Associated With Earlier Breast Cancer in BRCA1 Carriers
26 Sep 2012  |   BioResearch

Genetic Cause Identified for Severe Infant Epilepsy
26 Sep 2012  |   BioResearch

Study Reveals Diagnostic and Therapeutic Target in Rare Pancreatic Tumors
26 Sep 2012  |   BioResearch



INTEGRA BIOSCIENCES AG